Related Experiment Video
Updated: Apr 27, 2026

Generation of a Rat Model of Acute Liver Failure by Combining 70% Partial Hepatectomy and Acetaminophen
Published on: November 27, 2019
Pediatric acute liver failure: variations in referral timing are associated with disease subtypes
Ekkehard Sturm1, Willem S Lexmond, Henkjan J Verkade
1Pediatric Gastroenterology/Hepatology, Beatrix Children's Hospital, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands, ekkehard.sturm@med.uni-tuebingen.de.
Insights
Referral timing in pediatric acute liver failure (PALF) varies with clinical presentation. Early recognition of prognostic indicators and subacute liver failure (SLF) can improve PALF management.
Area of Science:
- Pediatric Hepatology
- Liver Transplantation
- Acute Liver Failure
Background:
- Rapid referral to a transplant center is crucial in pediatric acute liver failure (PALF).
- Clinical variability in PALF can impact the timing of referrals.
- Understanding referral patterns is key to optimizing patient management.
Purpose of the Study:
- To analyze the relationship between early or late referral timing and clinical characteristics in PALF.
- To investigate the impact of referral timing on patient outcomes.
- To identify factors associated with delayed referrals in PALF.
Main Methods:
- Retrospective, single-center comparative analysis of two PALF cohorts (early vs. late referral).
- Evaluation of clinical parameters, liver function tests, and prognostic indicators.
- Multivariate analysis to identify independent predictors of referral timing.
Main Results:
- Early referrals were associated with non-icteric presentation, lower hepatic encephalopathy grades, and lower bilirubin levels.
- Early referred patients had higher alanine aminotransferase (ALAT) levels and fewer poor prognostic indicators.
- Subacute liver failure (SLF) was independently associated with late referral.
Conclusions:
- Referral timing in PALF is linked to specific clinical and biochemical profiles.
- Early identification of prognostic signs and SLF is essential for timely referrals.
- Improving referral timing may enhance overall PALF management strategies.
Unlabelled:
In pediatric acute liver failure (PALF), rapid referral to a transplant center (TC) is advocated. Clinical variability of PALF may influence referral timing. We aimed to analyze early or late timing of referral in relation to clinical characteristics and outcome in PALF. We conducted a retrospective, single-center, comparative analysis of clinical and liver function parameters in two PALF cohorts (n = 23 per cohort): cohort 1 (early referral, duration of in-patient care before referral (DCR) <7 days) vs. cohort 2 (late referral, DCR ≥ 7 days). Compared to late referrals, patients referred early were more frequently non-icteric and encephalopathic at initial presentation (n = 14 vs. 5 and n = 13 vs. 4, each p < 0.05). Early referred PALF patients had lower hepatic encephalopathy (HE) grades and bilirubin (grade 1 vs. 2, p < 0.02; 215 vs. 439 μmol/l, p < 0.001, respectively) but higher alanine aminotransferase (ALAT) levels (4,340 vs. 963 U/l, p < 0.001). Cumulative poor prognostic indicators were lower in early referrals (2 vs. 4, p < 0.001). In multivariate analysis, subacute liver failure (SLF >7 days between disease onset and development of encephalopathy) was independently associated with late referral (relative risk 9.48; 95 % CI 1.37-64.85, p < 0.02). Differences in survival to discharge were not significant.
Conclusion:
In PALF, referral timing variability is associated with distinct clinical and liver function patterns. Early recognition of prognostic indicators and of SLF may help to improve referral timing and thus PALF management.
More Related Videos
05:56Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis
Published on: August 29, 2025
13:57Laparoscopic Anatomical Liver Segment VII Resection with Liver Parenchymal Transection Following a Priority Approach
Published on: May 23, 2025
Related Concept Videos
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Pharmacokinetics in Pediatric Patients: Drug Excretion
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Pharmacokinetics in Pediatric Patients: Drug Distribution